Long Covid Is an Elusive Target for Big Pharma

July 11, 2022

(Wall Street Journal) – The drug industry developed Covid-19 vaccines and treatments at breakneck speed, saving millions of lives in the process. Yet treatments for the post-viral illness known as long Covid, which is afflicting millions, are nowhere close to being developed. The lack of urgency around developing treatments is both a missed opportunity for the healthcare industry and a drag on the economy as an array of conditions such as dizziness and chest pain force many Americans to at least temporarily stop working. (Read More)